In the context of schizophrenia, Huang et al. (2018) demonstrated that NAC mitigates glutamatergic dysfunction associated with deficiency in the regulator of G-protein signaling 4 (RGS4) [77]. This evidence concerns the gene RGS4 and schizophrenia.